Dr. Murman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4242 Farnam Street
Ste 650
Omaha, NE 68198Phone+1 402-559-8600Fax+1 402-559-9510
Summary
- Dr. Daniel Murman is a neurologist based in Omaha, NE, specializing in cognitive, behavioral and geriatric neurology. He completed his medical education at the University of Nebraska College of Medicine and furthered his training with a residency and fellowship at the University of Michigan. He holds a Master's in Clinical Research Design and Biostatistics from the University of Michigan. His clinical and research expertise is focused on the evaluation and treatment of patients with neurodegenerative dementias, such as Alzheimer's disease, Lewy body dementias, and Frontotemporal Dementia. Dr. Murman's published research articles have focused on clinical and translational research of patients with neurodegenerative dementias, especially Alzheimer's disease. He has participated in multiple clinical trials related to Alzheimer's disease and recently Dementia with Lewy bodies.
Education & Training
University of Michigan School of Public HealthMS, Clinical Research Design and Biostatistics, 1995 - 1997
University of Michigan Health SystemFellowship, Behavioral and Geriatric Neurology, 1993 - 1996- University of MichiganResidency, Neurology, 1990 - 1993
Trinity Health Ann Arbor HospitalInternship, Internal Medicine, 1989 - 1990
University of Nebraska College of MedicineClass of 1989
Certifications & Licensure
NE State Medical License 2004 - 2026
MI State Medical License 1993 - 2006- American Board of Psychiatry and Neurology Neurology
- United Council of Neurologic SubspecialtiesBehavioral Neurology and Neuropsychiatry
- United Council of Neurologic SubspecialtiesGeriatric Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
- Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study Start of enrollment: 2015 Sep 08
- A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Start of enrollment: 2015 Nov 30
Publications & Presentations
PubMed
- Clinical Manifestations.Valentina Gumenyuk, Thomas Roth, Oleg Korzyukov, Nicholas Miller, Tristan Jones
Alzheimer's & Dementia. 2024-12-01 - 3 citationsAI-based differential diagnosis of dementia etiologies on multimodal data.Chonghua Xue, Sahana S Kowshik, Diala Lteif, Shreyas Puducheri, Varuna H Jasodanand
Nature Medicine. 2024-10-01 - 1 citationsAI-based differential diagnosis of dementia etiologies on multimodal data.Chonghua Xue, Sahana S Kowshik, Diala Lteif, Shreyas Puducheri, Varuna H Jasodanand
Medrxiv. 2024-03-26
Press Mentions
UNMC Neurologists Help Advance Science on AI Diagnosis of DementiaAugust 30th, 2024- UNMC Faculty Speak at Alzheimer's Foundation ConferenceDecember 4th, 2020
New Drug Showing Promise in Fight Against Alzheimer'sDecember 2nd, 2019- Join now to see all
Grant Support
- Predictors Of Direct Costs In Alzheimers DiseaseNational Institute On Aging1999–2003
Professional Memberships
- Fellow
- American Neurological AssociationFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
